Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000055

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 5, 2018
Accepted (ET)
Sep 10, 2018 · 2:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 5, 2018P2,000$0.0476A25,857,198D
Common StockSep 5, 2018P3,000$0.0476A25,860,198D
Common StockSep 5, 2018P1,000$0.0476A25,861,198D
Common StockSep 5, 2018P2,000$0.0476A25,863,198D
Common StockSep 5, 2018P1,000$0.0491A25,864,198D
Common StockSep 5, 2018P1,000$0.0491A25,865,198D
Common StockSep 5, 2018P1,000$0.0474A25,866,198D
Common StockSep 5, 2018P2,000$0.0473A25,868,198D
Common StockSep 5, 2018P1,000$0.0473A25,869,198D
Common StockSep 5, 2018P1,000$0.0478A25,870,198D
Common StockSep 5, 2018P1,000$0.0476A25,871,198D
Common StockSep 5, 2018P1,000$0.0476A25,872,198D
Common StockSep 5, 2018P1,000$0.0481A25,873,198D
Common StockSep 5, 2018P1,000$0.0475A25,874,198D
Common StockSep 5, 2018P1,000$0.0477A25,875,198D
Common StockSep 5, 2018P1,000$0.0475A25,876,198D
Common StockSep 6, 2018P1,000$0.0468A25,777,198D
Common StockSep 6, 2018P1,000$0.0451A25,878,198D
Common StockSep 6, 2018P1,000$0.0451A25,879,198D
Common StockSep 6, 2018P1,000$0.0388A25,880,198D
Common StockSep 6, 2018P1,000$0.0386A25,881,198D
Common StockSep 6, 2018P1,000$0.0389A25,882,198D
Common StockSep 6, 2018P1,000$0.0392A25,883,198D
Common StockSep 6, 2018P2,000$0.0391A25,885,198D
Common StockSep 6, 2018P3,000$0.0391A25,888,198D
Common StockSep 6, 2018P500$0.039A25,888,698D
Common StockSep 6, 2018P1,000$0.0386A25,889,698D
Common StockSep 6, 2018P2,000$0.0386A25,891,698D
Common StockSep 6, 2018P500$0.0386A25,892,198D
Common StockSep 6, 2018P1,000$0.0398A25,893,198D

Table II — derivative securities

No Table II lines on this filing.